Anti-Müllerian hormone (AMH) in the Diagnosis of Menstrual Disturbance Due to Polycystic Ovarian Syndrome

Overview of attention for article published in Frontiers in endocrinology, September 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news: 3 news outlets

twitter: 8 X users

Citations

dimensions_citation: 39 Dimensions

Readers on

mendeley: 116 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 3 news stories from 3 outlets.

Serum anti-Müllerian hormone as a predictor of polycystic ovarian syndrome among women of reproductive age | BMC Women's Health - daytonews

Day To News.com, 28 May 2022

Michelmore K.F., Balen A.H., Danger D.B., Vessey M.P. Polycystic ovaries and associated clinical and biochemical features in…

Anti-Müllerian Hormone a Potential Biomarker for Menstrual Disturbance in PCOS

Medical Health News, 10 Oct 2019

Serum anti-Müllerian hormone (AMH) may serve as a useful biomarker in the diagnosis of polycystic ovarian syndrome (PCOS)…

Anti-Müllerian Hormone a Potential Biomarker for Menstrual Disturbance in PCOS

Endocrinology Advisor, 10 Oct 2019

Serum anti-Müllerian hormone (AMH) may serve as a useful biomarker in the diagnosis of polycystic ovarian syndrome (PCOS)…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.